M69-11328-06147
3 vaccinations
3 coded responses
27 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 785 / TX
- Registered
- 2021-07-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
CDB-26929-45884
Child or adolescent in my care · Male · 2022-06-25
Timeline
-
2021-07-13
Registered in v-safe
-
2021-07-13
Dose 1 — Janssen/Johnson & Johnson
- 2021-07-13
-
2021-07-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Chills, Headache, Muscle or body aches, Nausea, Abdominal painAdult check-in
-
2021-07-15
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Redness, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-07-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint painsAdult check-in
-
2021-07-17
Survey response — days 1–6 daily, dose 1MedDRA: Injection site erythema, Injection site swelling — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, NauseaFree text: The swelling and redness around the injection site are increasing.MedDRA releases: 2024-11 · check-in free text available
-
2021-07-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-07-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · HeadacheAdult check-in
- 2021-07-20
- 2021-07-27
- 2021-08-03
- 2021-08-11
- 2021-08-19
- 2021-10-14
-
2021-10-29
Dose 2 — Janssen/Johnson & JohnsonCo-administered: Flu
- 2021-11-01
- 2021-11-03
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-10
- 2022-01-30
-
2022-10-14
Dose 3 — ModernaCo-administered: Flu
- 2022-10-18
- 2022-10-23
- 2022-10-29
- 2022-11-13
-
2022-11-19
Survey response — day 35, dose 3MedDRA: Cough, Headache, Pain, Rhinorrhoea — Feeling: Poor · Be unable to work or attend schoolFree text: Runny nose, cough, body aches, headacheMedDRA releases: 2024-11 · check-in free text available
-
2023-01-15
Survey response — 3 months, dose 3MedDRA: Bronchitis, Cough, Respiratory tract congestion, Sinus headache, Sinusitis — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-15
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-13 | Janssen/Johnson & Johnson | No |
| 2 | 2021-10-29 | Janssen/Johnson & Johnson | Flu |
| 3 | 2022-10-14 | Moderna | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): The swelling and redness around the injection site are increasing.
Release 12 — day 35, dose 3
Symptoms: Runny nose, cough, body aches, headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinus headache | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release